Encompass Health Corporation Equity Securities, FV-NI, Unrealized Gain (Loss)
Encompass Health Corporation (EHC) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of $2.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2026-08-07
- Encompass Health Corporation equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2026-06-30 was $2.30M, a 187.50% increase year-over-year.
- Encompass Health Corporation equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2026-03-31 was -$200.00K, a 128.57% decline year-over-year.
- Encompass Health Corporation equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-12-31 was $300.00K.
- Encompass Health Corporation equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-09-30 was $1.00M, a 64.29% decline year-over-year.
- Encompass Health Corporation equity securities, fv-ni, unrealized gain (loss) for fiscal 2025 was $2.10M, a 110.00% increase from fiscal 2024.
- Encompass Health Corporation equity securities, fv-ni, unrealized gain (loss) for fiscal 2024 was $1.00M, a 23.08% decline from fiscal 2023.
- Encompass Health Corporation equity securities, fv-ni, unrealized gain (loss) for fiscal 2023 was $1.30M.
- Encompass Health Corporation equity securities, fv-ni, unrealized gain (loss) for fiscal 2022 was -$7.40M, a 1333.33% decline from fiscal 2021.
| Period end | Equity Securities, FV-NI, Unrealized Gain (Loss) 3 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 6 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 9 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 12 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $2.30M 10-Q · filed 2026-08-07 | $3.50M 10-Q · filed 2026-08-07 | $2.40M derived: sum of 3 quarters · filed 2026-08-07 | $3.40M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | -$200.00K 10-Q · filed 2026-05-01 | $100.00K derived: sum of 2 quarters · filed 2026-05-01 | $1.10M derived: sum of 3 quarters · filed 2026-05-01 | $1.90M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.30M derived: sum of 2 quarters · filed 2026-02-26 | $2.10M derived: sum of 3 quarters · filed 2026-08-07 | $2.10M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $1.00M 10-Q · filed 2025-10-31 | $1.80M derived: sum of 2 quarters · filed 2026-08-07 | $1.80M 10-Q · filed 2025-10-31 | $800.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $800.00K 10-Q · filed 2026-08-07 | $800.00K 10-Q · filed 2026-08-07 | -$200.00K derived: sum of 3 quarters · filed 2026-08-07 | $2.60M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $700.00K 10-Q · filed 2026-05-01 | -$1.00M derived: sum of 2 quarters · filed 2026-05-01 | $1.80M derived: sum of 3 quarters · filed 2026-05-01 | $1.30M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.10M derived: sum of 2 quarters · filed 2026-02-26 | $600.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.00M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $2.80M 10-Q · filed 2025-10-31 | $2.30M derived: sum of 2 quarters · filed 2025-10-31 | $2.70M 10-Q · filed 2025-10-31 | ||
| 2024-06-30 | -$500.00K 10-Q · filed 2025-08-06 | -$100.00K 10-Q · filed 2025-08-06 | |||
| 2023-12-31 | $1.30M 10-K · filed 2026-02-26 | ||||
| 2022-12-31 | -$7.40M 10-K · filed 2025-02-28 | ||||
| 2021-12-31 | $600.00K 10-K · filed 2024-02-28 | ||||
| 2020-12-31 | $400.00K 10-K · filed 2023-02-27 | ||||
| 2019-12-31 | $1.20M 10-K · filed 2022-02-25 | ||||
| 2018-12-31 | -$1.70M 10-K · filed 2021-02-26 | $1.70M 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |